Cov19 Mutates with Categories

 

Variants of interest

The following are classified as variants of interest. These variants may potentially be less receptive to monoclonal antibody treatments and vaccines:

• B.1.526 (first detected in New York in November 2020)
• B.1.525 (first detected in New York in December 2020)
• P.2 (first detected in Brazil in April 2020)
• B.1.617 (first detected in India in February 2021)
• B.1.617.1 (first detected in India in December 2020)
• B.1.617.3 (first detected in India in October 2020)

Variants of concern

The following are classified as variants of concern. Variants of concern may spread more easily, cause more severe disease (more hospitalizations or deaths), lead to less generation of antibodies, have less efficacy in treatment or vaccines, or cause failures with diagnosis.

• B.1.1.7 (first detected in the United Kingdom)
• P.1 (first detected in Japan and Brazil)
• B.1.351 (first detected in South Africa)
• B.1.427 and B.1.429 (first detected in California)

Variants of high consequence

Variants of high consequence are associated with diagnostic failure, significantly reduced vaccine efficacy (or an unusually high number of COVID-19 cases in vaccinated people), inadequate response to treatment, and more severe illness and higher number of hospitalizations. 

According to the U.S. Centers for Disease Control and Prevention (CDC), “a variant of high consequence would require notification to WHO under the International Health Regulations, reporting to CDC, an announcement of strategies to prevent or contain transmission, and recommendations to update treatments and vaccines.”

Currently, there are no coronavirus variants of high consequence. 

...

Ps. This article is a quote.